- Work In Greater Copenhagen
- For employers
Ascendis Pharma is building an integrated, rare disease-focused biopharmaceutical company to advance its pipeline of long-acting prodrug therapies.
Ascendis Pharma is building an integrated, rare disease-focused biopharmaceutical company to advance its pipeline of long-acting prodrug therapies. The company is listed on the NASDAQ US stock exchange and is led by President and CEO Jan Mikkelsen.
In Ascendis Pharma we are working towards a number of long-term strategic goals, outlined in a business plan called “Vision 20/20”. This plan reflects our mission to create best-in-class rare disease products that address unmet medical needs by utilizing our TransCon technology to improve parent drugs with demonstrated clinical proof-of-concept.
To achieve this, we are creating strategic teams of highly experienced people across Europe and the United States to conduct our operations. In addition to experience and talent, we seek individuals who are flexible and highly resourceful. We also believe that by maintaining a lean organization, we obtain a high level of innovation and at the same time facilitate rapid product development from discovery stage to clinical development to commercialization.
Ascendis Pharma is headquartered in Copenhagen, Denmark, maintains an office in Palo Alto, California and has research and development facilities in Heidelberg, Germany and Copenhagen, Denmark. Ascendis Pharma globally employs around 145 people.
If you want to be part of a growing company, we are constantly looking for new talents to join us. You will be offered an exciting and challenging position in an entrepreneurial and international company. Being part of an Ascendis Pharma team, you will be involved in activities that are central to Ascendis Pharma’s strategy and work together with highly skilled and experienced colleagues to advance our exciting product pipeline.